Comprehensive In Vitro and In Silico Aerodynamic Analysis of High-Dose Ibuprofen- and Mannitol-Containing Dry Powder Inhalers for the Treatment of Cystic Fibrosis
Petra Party, Zsófia Ilona Piszman, Árpád Farkas, Rita Ambrus, Nazrul Islam, Alhajj Nasser · 2024
Read Comprehensive In Vitro and In Silico Aerodynamic Analysis of High-Dose Ibuprofen- and Mannitol-Containing Dry Powder Inhalers for the Treatment of Cystic Fibrosis by Petra Party, Zsófia Ilona Piszman, Árpád Farkas, Rita Ambrus, Nazrul Islam, Alhajj Nasser (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11597309.txt.
Description
Researchers developed two dry powder inhalers in 2024 for people with cystic fibrosis, a lung disease with thick mucus and sore airways. One powder holds mannitol alone, which thins mucus. The other holds mannitol plus ibuprofen, which eases swelling. Both use far less drug than pills for the same effect.
Powders were milled, mixed with leucine, and spray-dried into light round grains of the right size. Lab tests of size, shape, lung spread, and drug release in fake lung fluid looked good. A lung model on a computer also showed strong spread to the lungs.
Catalog record
| CREATOR | Petra Party, Zsófia Ilona Piszman, Árpád Farkas, Rita Ambrus, Nazrul Islam, Alhajj Nasser |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |